Home » Business » Curevac, which develops vaccine against Covid-19, captures US $ 213 million in output to Nasdaq

Curevac, which develops vaccine against Covid-19, captures US $ 213 million in output to Nasdaq

Biotech CureVac BV said on Friday it raised $ 213.3 million on its exit to bag in New York, in which it will be the first jump to the market of a company that is developing a potential vaccine to combat the coronavirus.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.